BackGlobal Blood Therapeutics Overview

Global Blood Therapeutics Other Income Expense Net

Other Income/Expense Net for GBT.

Quarterly Other Income/Expense

-$8.40M
↓ 138.56% YoY

As of Jun 30, 2022

Annual Other Income/Expense (TTM)

-$24.22M
↓ 118.36% YoY

Trailing 12 months ending Jun 30, 2022

Average Other Income/Expense (Comparison Companies)

Other Income Expense Net History

Other Income Expense Net Comparison

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin